PLIANT THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pliant Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.9M, a 14.1% decline year-over-year.
  • Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $38.4M, a 16.9% decline year-over-year.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.5M, a 96.8% increase from 2022.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.6M, a 117% increase from 2021.
  • Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.4M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $44.5M +$21.9M +96.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $22.6M +$12.2M +117% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $10.4M +$6.54M +168% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $3.9M +$2.07M +113% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $1.83M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.